>latest-news

Kobayashi Pharmaceutical Faces Scrutiny for Failing to Report Products

Kobayashi Pharma failed to report red fermented rice items; ministry demands report by Wednesday.

Breaking News

  • Jul 27, 2024

  • Mrudula Kulkarni

Kobayashi Pharmaceutical Faces Scrutiny for Failing to Report Products

Japan's Kobayashi Pharmaceutical Co. said on Friday that it had neglected to notify the health ministry about certain items that it had sold to five businesses that included its red fermented rice, or "beni koji."

As an original equipment manufacturer, Kobayashi Pharmaceutical delivered the items to the five firms. Kobayashi Pharmaceutical stated that it had believed that these items were exempt from the ministry's requirement for reporting.

The Osaka-based firm was asked by the ministry to submit items that had the same quantity of beni koji—or more—than the supplements that were the subject of the health danger controversy.It was discovered in June that Kobayashi Pharmaceutical had omitted certain deaths that were allegedly connected to the aforementioned supplements.

The government claims that none of the goods produced by the five firms are now on the market. If there are any goods other than those of the five firms that contain beni koji and are required to reporting, Kobayashi Pharmaceutical has been requested by the government to report by Wednesday.

Ad
Advertisement